The largest database of trusted experimental protocols

Phadia immunocap 250 analyzer

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Phadia ImmunoCAP® 250 analyzer is a laboratory instrument designed for the quantitative measurement of specific IgE antibodies in human serum or plasma samples. The analyzer uses a solid-phase fluorescent enzyme immunoassay technology to determine the levels of specific IgE antibodies to a wide range of allergens.

Automatically generated - may contain errors

3 protocols using phadia immunocap 250 analyzer

1

Culturing PBMCs to Study PR3-ANCA Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated and cultured as described before (15 (link)). In short, for 79 GPA patients PBMCs were available and were cultured for 12 days with or without 3.2 μg/mL CpG-ODN 2006 (Hycult Biotech, Uden, the Netherlands), 100 ng/mL IL-21 (Immunotools, Friesoythe, Germany) and 100 ng/mL BAFF (PeproTech Inc., Rocky Hill, CT, USA). Stimulated and spontaneous PR3-ANCA (RU/mL) production was determined in the supernatant by Phadia ImmunoCAP® 250 analyzer using EliA PR3S (Thermo Fisher Scientific) and total spontaneous and stimulated IgG production was assessed by ELISA. Five samples (2 F-R and 3 N-R) were excluded because of a culture infection.
+ Open protocol
+ Expand
2

ANCA Testing Protocol for Autoimmune Diseases

Check if the same lab product or an alternative is used in the 5 most similar protocols
ANCA detection was performed by indirect immunofluorescence, as described previously (14 (link)). ANCA titers of 1:40 or higher were considered positive. Serum PR3-ANCA levels could be determined in samples of 51 patients by Phadia ImmunoCAP® 250 analyzer using EliA PR3S (Thermo Fisher Scientific, Waltham, MA, USA).
+ Open protocol
+ Expand
3

In Vitro Quantification of PR3-ANCA IgG in GPA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture and quantification of total and PR3-ANCA IgG was performed as previously described by our group (22 (link)). Briefly, peripheral blood mononuclear cells (PBMCs) were isolated from GPA patients, who produce ANCA upon in vitro induction (20 (link)), and stored in RPMI 1640 (Lonza, Basel, Switzerland) supplemented with 50 µg/mL gentamycin (GIBCO, Life Technologies, Grand Island, NY, USA), 10% fetal calf serum (FCS, Lonza), and 10% dimethyl sulfoxide (DMSO). Cryopreserved PBMCs were thawed, and cell suspensions were adjusted to 106 cells/ml in RPMI + 10% FCS. Cells were seeded in 48-well plates (Corning, NY, USA) and stimulated with 3.2 µg/ml CpG-oligodeoxynucleotides (ODN) 2006 (Hycult Biotech, Uden, the Netherlands), 100 ng/ml B cell-activating factor (BAFF; PeproTech Inc., Rocky Hill, NJ, USA), and 100 ng/ml IL-21 (Immunotools, Friesoythe, Germany) at 37°C with 5% CO2, in the presence and absence of 1 nM ShK-186 (Kineta Inc., Seattle, WA, USA). After 12 days, the culture supernatants were harvested and levels of both total IgG and PR3-ANCA IgG were determined using in-house enzyme-linked immunosorbent assay and Phadia ImmunoCAP 250 analyzer with EliA PR3S (Thermo Fisher Scientific, Waltham, MA, USA), respectively. Levels of PR3-ANCA IgG are expressed as response units (RU) per milliliter.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!